Biorelevant characterization system for subcutaneous injections
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
|---|---|
| State: | Missouri |
| Type of Government: | Federal |
| FSC Category: |
|
| NAICS Category: |
|
| Set Aside: | Total Small Business Set-Aside (FAR 19.5) |
| Posted Date: | Apr 28, 2025 |
| Due Date: | May 9, 2025 |
| Solicitation No: | 75F401F25R00066 |
| Original Source: | Please Login to View Page |
| Contact information: | Please Login to View Page |
| Bid Documents: | Please Login to View Page |
Description
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
- Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
- Original Published Date: Apr 28, 2025 05:39 pm EDT
- Original Date Offers Due: May 09, 2025 12:00 pm EDT
- Inactive Policy: 15 days after date offers due
- Original Inactive Date: May 24, 2025
-
Initiative:
- None
- Original Set Aside: Total Small Business Set-Aside (FAR 19.5)
- Product Service Code: 6640 - LABORATORY EQUIPMENT AND SUPPLIES
-
NAICS Code:
- 334516 - Analytical Laboratory Instrument Manufacturing
-
Place of Performance:
Saint Louis , MO 63110USA
The scope is to purchase and install an in vitro biorelevant characterization system for subcutaneous injections at the injection site in an artificial extracellular matrix (ECM) with integrated camera and turbidity sensors, inline fiber optic probes, pH monitors, and an automated sample fraction collector for unattended operation and media refill after sampling. The aim is to expand and augment the capacity and capability of CDER/OPQ/OPQR to ensure quality, safety and efficacy of pharmaceutical products. In particular, this in vitro system will offer the capability for investigating the release performance of subcutaneous formulations under simulated physiological conditions. It assesses the critical drug attributes, risk and performance of subcutaneously administered drugs including biologics, peptides and small molecules.
- 4041 Powder Mill Road 4th Floor
- Beltsville , MD 20705
- USA
- Erika Crawford
- erika.crawford@fda.hhs.gov
- Phone Number 3017960298
- Apr 28, 2025 05:39 pm EDTCombined Synopsis/Solicitation (Original)
Related Document
| Apr 29, 2025 | [Combined Synopsis/Solicitation (Updated)] Biorelevant characterization system for subcutaneous injections |
See Also
Bid Information Type Request for Bid Status Issued Number 27-0038 (Plasma Enhanced Chemical
University of Missouri System
Due by 9/29/2026
Type Number Description Due By Opening Status INVITATION FOR BID 2273 GAS MASK
St. Louis County
Due by 9/22/2026
Basic Information Negotiation MODOT KC 0000000071SL Title RTK Locator Kits for MoDOT KC
State Government of Missouri
Due by 9/24/2026
Follow Rapid ID and AST System Active Contract Opportunity Notice ID 36C25526Q0653 Related
VETERANS AFFAIRS, DEPARTMENT OF
Due by 9/22/2026